Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 33

Results: 15

EZH2 promotes a bi-lineage identity in basal-like breast cancer cells.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3886, doi. 10.1038/onc.2012.390
By:
- Granit, R Z;
- Gabai, Y;
- Hadar, T;
- Karamansha, Y;
- Liberman, L;
- Waldhorn, I;
- Gat-Viks, I;
- Regev, A;
- Maly, B;
- Darash-Yahana, M;
- Peretz, T;
- Ben-Porath, I
Publication type:
Article
Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3904, doi. 10.1038/onc.2013.5
By:
- Lin, Y-H;
- Huang, Y-H;
- Wu, M-H;
- Wu, S-M;
- Chi, H-C;
- Liao, C-J;
- Chen, C-Y;
- Tseng, Y-H;
- Tsai, C-Y;
- Tsai, M-M;
- Lin, K-H
Publication type:
Article
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3809, doi. 10.1038/onc.2012.389
By:
- Sampson, E R;
- McMurray, H R;
- Hassane, D C;
- Newman, L;
- Salzman, P;
- Jordan, C T;
- Land, H
Publication type:
Article
The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3819, doi. 10.1038/onc.2012.406
By:
- Guan, D;
- Factor, D;
- Liu, Yu;
- Wang, Z;
- Kao, H-Y
Publication type:
Article
YAP1 oncogene and its eight isoforms.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3922, doi. 10.1038/onc.2012.520
By:
- Sudol, M
Publication type:
Article
The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3840, doi. 10.1038/onc.2012.399
By:
- Koyama-Nasu, R;
- Nasu-Nishimura, Y;
- Todo, T;
- Ino, Y;
- Saito, N;
- Aburatani, H;
- Funato, K;
- Echizen, K;
- Sugano, H;
- Haruta, R;
- Matsui, M;
- Takahashi, R;
- Manabe, E;
- Oda, T;
- Akiyama, T
Publication type:
Article
C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3896, doi. 10.1038/onc.2012.380
By:
- Barroilhet, L;
- Yang, J;
- Hasselblatt, K;
- Paranal, R M;
- Ng, S-K;
- Rauh-Hain, J A;
- Welch, W R;
- Bradner, J E;
- Berkowitz, R S;
- Ng, S-W
Publication type:
Article
BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3877, doi. 10.1038/onc.2012.392
By:
- Tripurani, S K;
- Cook, R W;
- Eldin, K W;
- Pangas, S A
Publication type:
Article
FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3798, doi. 10.1038/onc.2012.393
By:
- Dikshit, B;
- Irshad, K;
- Madan, E;
- Aggarwal, N;
- Sarkar, C;
- Chandra, P S;
- Gupta, D K;
- Chattopadhyay, P;
- Sinha, S;
- Chosdol, K
Publication type:
Article
The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3857, doi. 10.1038/onc.2012.395
By:
- Wang, Y;
- Wang, Z;
- Joshi, B H;
- Puri, R K;
- Stultz, B;
- Yuan, Q;
- Bai, Y;
- Zhou, P;
- Yuan, Z;
- Hursh, D A;
- Bi, X
Publication type:
Article
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3829, doi. 10.1038/onc.2012.405
By:
- Ketchart, W;
- Smith, K M;
- Krupka, T;
- Wittmann, B M;
- Hu, Y;
- Rayman, P A;
- Doughman, Y Q;
- Albert, J M;
- Bai, X;
- Finke, J H;
- Xu, Y;
- Exner, A A;
- Montano, M M
Publication type:
Article
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3867, doi. 10.1038/onc.2012.394
By:
- Norris, A M;
- Gore, A;
- Balboni, A;
- Young, A;
- Longnecker, D S;
- Korc, M
Publication type:
Article
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3915, doi. 10.1038/onc.2012.403
By:
- Franzetti, G-A;
- Laud-Duval, K;
- Bellanger, D;
- Stern, M-H;
- Sastre-Garau, X;
- Delattre, O
Publication type:
Article
Various modes of cell death induced by DNA damage.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3789, doi. 10.1038/onc.2012.556
By:
- Surova, O;
- Zhivotovsky, B
Publication type:
Article
HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.
Published in:
Oncogene, 2013, v. 32, n. 33, p. 3846, doi. 10.1038/onc.2012.396
By:
- Gusenbauer, S;
- Vlaicu, P;
- Ullrich, A
Publication type:
Article